You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Apatinib

Showing 451 - 467 of 467
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenocarcinoma of Lung Trial (Cytokine-Induced Killer Cells, Apatinib)

Active, not recruiting
  • Adenocarcinoma of Lung
  • Cytokine-Induced Killer Cells
  • Apatinib
  • (no location specified)
Feb 4, 2016

HCC Trial in Zhengzhou (Basic drugs therapy of HCC, Arginine HCl, Trimetazidine HCl)

Unknown status
  • HCC
  • Basic drugs therapy of HCC
  • +2 more
  • Zhengzhou, Henan, China
    The First Affiliated Hospital of Zhengzhou University
Sep 9, 2017

An Open Label, Prospective, Multicentre, Non-interventional

Unknown status
  • Metastatic Gastric Cancer
    • Beijing, Beijing, China
      Department of Oncology and Surgery, Peking Union Medical College
    Jan 28, 2016

    HCC Trial in Zhengzhou (Basic drugs therapy of HCC by TACE, Arginine HCl, Trimetazidine HCl)

    Unknown status
    • HCC
    • Basic drugs therapy of HCC by TACE
    • +2 more
    • Zhengzhou, Henan, China
      The First Affiliated Hospital of Zhengzhou University
    Sep 14, 2017

    Gastric Carcinoma Trial in Shanghai (Docetaxel, apatinib)

    Unknown status
    • Gastric Carcinoma
    • Shanghai, Shanghai, China
      Zhongshan Hospital Affiliated to Fudan University
    Nov 17, 2015

    Metastatic Breast Cancer Trial in Shanghai (Apatinib)

    Completed
    • Metastatic Breast Cancer
    • Apatinib
    • Shanghai, Shanghai, China
      Fudan University Cancer Hospital
    Sep 8, 2015

    NSCLC Trial in Shanghai (Apatinib single agent arm)

    Unknown status
    • Non-small Cell Lung Cancer
    • Apatinib single agent arm
    • Shanghai, China
      Department of Oncology, Shanghai pulmonary hospital
    Sep 3, 2015

    Gastric Cancer Trial (Apatinib, S-1)

    Unknown status
    • Gastric Cancer
    • (no location specified)
    Aug 14, 2015

    Colorectal Cancer Trial in Shanghai (Apatinib, apatinib)

    Completed
    • Colorectal Cancer
    • Apatinib
    • apatinib
    • Shanghai, Shanghai, China
      Fudan University cancer hospital
    Apr 2, 2015

    Advanced Hepatocellular Carcinoma Trial in Nanjin, (Apatinib)

    Completed
    • Advanced Hepatocellular Carcinoma
    • Apatinib
    • Nanjin,, Jiangsu, China
      Nanjin Military Eighty -one Hosiptal
    Apr 2, 2015

    Colorectal Tumors Trial (Cytokine-Induced Killer Cells)

    Active, not recruiting
    • Colorectal Neoplasms
    • Cytokine-Induced Killer Cells
    • (no location specified)
    Feb 23, 2016

    Stomach Tumors Trial in Shanghai (Irinotecan)

    Unknown status
    • Stomach Neoplasms
    • Shanghai, Shanghai, China
      Shanghai Cancer Center
    Jan 21, 2016

    NSCLC Trial in Guangzhou (apatinib, )

    Unknown status
    • Non-small Cell Lung Cancer
    • apatinib
    • placebo
    • Guangzhou, Guangdong, China
      Cancer Center of Sun Yat-Sen University (CCSU)
    Dec 5, 2013

    Breast Tumors Trial in Shanghai (Apatinib)

    Completed
    • Breast Neoplasms
    • Apatinib
    • Shanghai, Shanghai, China
    • +1 more
    Dec 2, 2013

    Non-Small-Cell Lung Cancer Trial in Guangzhou (apatinib, )

    Completed
    • Non-Small-Cell Lung Cancer
    • apatinib
    • placebo
    • Guangzhou, Guangdong, China
      Department of Medical Oncology, Cancer Center, Sun Yet-sen Unive
    Feb 9, 2012

    Gastric Carcinoma Trial in ShangHai (apatinib tablet)

    Completed
    • Gastric Carcinoma
    • apatinib tablet
    • ShangHai, Shanghai, China
      Fudan University Cancer Hospital
    Jul 11, 2011

    Tumor Trial in Shanghai (apatinib)

    Unknown status
    • Tumor
    • apatinib
    • Shanghai, Shanghai, China
      Fudan University Cancer Hospital
    Jul 21, 2008